EVS
Short position disclosed on July 28, 2026.
0.80% of the capital sold short
1 disclosing funds
1 disclosures on record
BE0003820371 ISIN code
Funds holding EVS Titelia
Evolution of the disclosed total
0%0.2%0.4%0.6%0.8%
Jul 31Aug 3Aug 6Aug 9Aug 12
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Citadel Advisors LLC | 0.80% | unchanged | July 28, 2026 |
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| July 28, 2026 | Citadel Advisors LLC | 0.80% | still open |
Other companies sold short in Belgium
- Solvay 2.07% of the capital sold short
- Biocartis 1.21% of the capital sold short
- Barco 1.02% of the capital sold short
- CP Invest 0.98% of the capital sold short
- D'Ieteren Group 0.89% of the capital sold short
- Syensqo 0.89% of the capital sold short
- Azelis 0.71% of the capital sold short
- Umicore 0.70% of the capital sold short
- Lotus Bakeries 0.69% of the capital sold short
- Sequana Medical 0.69% of the capital sold short
- WDP 0.51% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, EVS, source FSMA, data as at July 28, 2026, https://www.quivad.com/action/evs